696
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy of Levetiracetam in neonatal seizures: a systematic review

, &
Pages 3923-3930 | Received 07 May 2020, Accepted 28 Oct 2020, Published online: 10 Nov 2020

References

  • El-Dib M, Soul JS. The use of phenobarbital and other anti-seizure drugs in newborns. Semin Fetal Neonatal Med. 2017;22(5):321–327.
  • Ghanshyambhai P, Sharma D, Patel A, et al. To study the incidence, etiology and EEG profile of neonatal seizures: a prospective observational study from India. J Matern-Fetal Neonatal Med. 2016;29(4):554–558.
  • Lanska MJ, Lanska DJ. Neonatal seizures in the United States: results of the National Hospital Discharge Survey, 1980–1991. Neuroepidemiology. 1996;15(3):117–125.
  • Vasudevan C, Levene M. Epidemiology and aetiology of neonatal seizures. Semin Fetal Neonatal Med. 2013;18(4):185–191.
  • Pisani F, Facini C, Pavlidis E, et al. Epilepsy after neonatal seizures: literature review. Eur J Paediatr Neurol. 2015;19(1):6–14.
  • Ahmad KA, Desai SJ, Bennett MM, et al. Changing antiepileptic drug use for seizures in US neonatal intensive care units from 2005 to 2014. J Perinatol. 2017;37(3):296–300.
  • Forcelli PA, Janssen MJ, Vicini S, et al. Neonatal exposure to antiepileptic drugs disrupts striatal synaptic development. Ann Neurol. 2012;72(3):363–372.
  • Rosselli-Austin L, Yanai J. Neuromorphological changes in mouse olfactory bulb after neonatal exposure to phenobarbital. Neurotoxicol Teratol. 1989;11(3):227–230.
  • Bittigau P, Sifringer M, Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann NY Acad Sci. 2003;993(1):103–114.
  • Maitre NL, Smolinsky C, Slaughter JC, et al. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures. J Perinatol. 2013;33(11):841–846.
  • Forcelli PA, Janssen MJ, Stamps LA, et al. Therapeutic strategies to avoid long-term adverse outcomes of neonatal antiepileptic drug exposure. Epilepsia. 2010;51(Suppl 3):18–23.
  • Sulzbacher S, Farwell JR, Temkin N, et al. Late cognitive effects of early treatment with phenobarbital. Clin Pediatr. 1999;38(7):387–394.
  • van Rooij LGM, Hellström-Westas L, de Vries LS. Treatment of neonatal seizures. Semin Fetal Neonatal Med. 2013;18(4):209–215.
  • Beierle S, Laengvejkal P. Keppra a magical antiepileptic medication. SWRCCC. 2013;1(2):16–19.
  • Mruk AL, Garlitz KL, Leung NR. Levetiracetam in neonatal seizures: a review. J Pediatr Pharmacol Ther. 2015;20(2):76–89.
  • Kim J-S, Kondratyev A, Tomita Y, et al. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia. 2007;48(Suppl 5):19–26.
  • Lyseng-Williamson KA. Spotlight on levetiracetam in epilepsy. CNS Drugs. 2011;25(10):901–905.
  • Loiacono G, Masci M, Zaccara G, et al. The treatment of neonatal seizures: focus on Levetiracetam. J Matern-Fetal Neonatal Med. 2016;29(1):69–74. DOI:10.3109/14767058.2014.986651. Epub 2014 Dec 5. PMID: 25385270.
  • Falsaperla R, Mauceri L, Pavone P, et al. Short-term neurodevelopmental outcome in term neonates treated with phenobarbital versus levetiracetam: a single-center experience. Behav Neurol. 2019;2019:3683548.
  • Khan O, Chang E, Cipriani C, et al. Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol. 2011;44(4):265–269.
  • Shoemaker MT, Rotenberg JS. Levetiracetam for the treatment of neonatal seizures. J Child Neurol. 2007;22(1):95–98.
  • Meehan AL, Yang X, McAdams BD, et al. A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam. J Neurophysiol. 2011;106(3):1227–1239.
  • Falsaperla R, Vitaliti G, Mauceri L, et al. Levetiracetam in neonatal seizures as first-line treatment: a prospective study. J Pediatr Neurosci. 2017;12(1):24–28. Mar
  • Rao LM, Hussain SA, Zaki T, et al. A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic-ischemic encephalopathy. Epilepsy Behav. 2018;88:212–217.
  • Venkatesan C, Young S, Schapiro M, et al. Levetiracetam for the Treatment of Seizures in Neonatal Hypoxic Ischemic Encephalopathy. J Child Neurol. 2017;32(2):210–214.
  • Han JY, Moon CJ, Youn YA, Sung IK, et al. Efficacy of levetiracetam for neonatal seizures in preterm infants. BMC Pediatr. 2018; 18(1):131.
  • Kreimer AM, Littrell RA, Gibson JB, et al. Effectiveness of levetiracetam as a first-line anticonvulsant for neonatal seizures. J Pediatr Pharmacol Ther. 2019;24(4):320–326.
  • Sedighi M, Asadi F, Moradian N, et al. Efficacy and safety of levetiracetam in the management of seizures in neonates. Neurosciences. 2016;21(3):232–235.
  • Gowda VK, Romana A, Shivanna NH, et al. Levetiracetam versus phenobarbitone in neonatal seizures – a randomized controlled trial. Indian Pediatr. 2019;56(8):643–646.
  • Efficacy of intravenous levetiracetam in neonatal seizures. ClinicalTrials.gov [Internet]. [cited 2020 May 7]. Available from: https://clinicaltrials.gov/ct2/show/NCT01720667.
  • Efficacy of levetiracetam in control of neonatal seizures guided by an EEG. ClinicalTrials.gov. [Internet]. [cited 2020 May 7]. Available from: https://clinicaltrials.gov/ct2/show/NCT03107507.
  • Levetiracetam treatment of neonatal seizures. ClinicalTrials.gov [Internet]. [cited 2020 May 7]. Available from: https://clinicaltrials.gov/ct2/show/NCT02550028.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.